These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 7563055)

  • 1. Thermodynamic mapping of the inhibitor site of the aspartic protease endothiapepsin.
    Gómez J; Freire E
    J Mol Biol; 1995 Sep; 252(3):337-50. PubMed ID: 7563055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residues.
    Xie D; Gulnik S; Collins L; Gustchina E; Suvorov L; Erickson JW
    Biochemistry; 1997 Dec; 36(51):16166-72. PubMed ID: 9405050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of resistance to HIV-1 protease inhibition: a plausible hypothesis.
    Luque I; Todd MJ; Gómez J; Semo N; Freire E
    Biochemistry; 1998 Apr; 37(17):5791-7. PubMed ID: 9558312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculating proton uptake/release and binding free energy taking into account ionization and conformation changes induced by protein-inhibitor association: application to plasmepsin, cathepsin D and endothiapepsin-pepstatin complexes.
    Alexov E
    Proteins; 2004 Aug; 56(3):572-84. PubMed ID: 15229889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural stability of the HIV-1 protease.
    Todd MJ; Semo N; Freire E
    J Mol Biol; 1998 Oct; 283(2):475-88. PubMed ID: 9769219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray analyses of aspartic proteinases. The three-dimensional structure at 2.1 A resolution of endothiapepsin.
    Blundell TL; Jenkins JA; Sewell BT; Pearl LH; Cooper JB; Tickle IJ; Veerapandian B; Wood SP
    J Mol Biol; 1990 Feb; 211(4):919-41. PubMed ID: 2179568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The energetics of HMG box interactions with DNA: thermodynamics of the DNA binding of the HMG box from mouse sox-5.
    Privalov PL; Jelesarov I; Read CM; Dragan AI; Crane-Robinson C
    J Mol Biol; 1999 Dec; 294(4):997-1013. PubMed ID: 10588902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of inhibitor binding on the structural stability and cooperativity of the HIV-1 protease.
    Todd MJ; Freire E
    Proteins; 1999 Aug; 36(2):147-56. PubMed ID: 10398363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based thermodynamic design of peptide ligands: application to peptide inhibitors of the aspartic protease endothiapepsin.
    Luque I; Gómez J; Semo N; Freire E
    Proteins; 1998 Jan; 30(1):74-85. PubMed ID: 9443342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the energetics of a protein-protein interaction: the binding of ovomucoid third domain to elastase.
    Baker BM; Murphy KP
    J Mol Biol; 1997 May; 268(2):557-69. PubMed ID: 9159490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energetics of target peptide recognition by calmodulin: a calorimetric study.
    Wintrode PL; Privalov PL
    J Mol Biol; 1997 Mar; 266(5):1050-62. PubMed ID: 9086281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment reconstitution of a small protein: folding energetics of the reconstituted immunoglobulin binding domain B1 of streptococcal protein G.
    Honda S; Kobayashi N; Munekata E; Uedaira H
    Biochemistry; 1999 Jan; 38(4):1203-13. PubMed ID: 9930980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic dissection of the binding energetics of KNI-272, a potent HIV-1 protease inhibitor.
    Velazquez-Campoy A; Luque I; Todd MJ; Milutinovich M; Kiso Y; Freire E
    Protein Sci; 2000 Sep; 9(9):1801-9. PubMed ID: 11045625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitor.
    Gutiérrez-de-Terán H; Nervall M; Dunn BM; Clemente JC; Aqvist J
    FEBS Lett; 2006 Oct; 580(25):5910-6. PubMed ID: 17045991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamic characterization of the binding of tetrahydropterins to phenylalanine hydroxylase.
    Pey AL; Thórólfsson M; Teigen K; Ugarte M; Martínez A
    J Am Chem Soc; 2004 Oct; 126(42):13670-8. PubMed ID: 15493924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificity.
    Cronin NB; Badasso MO; J Tickle I; Dreyer T; Hoover DJ; Rosati RL; Humblet CC; Lunney EA; Cooper JB
    J Mol Biol; 2000 Nov; 303(5):745-60. PubMed ID: 11061973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of the behaviour of an aspartic proteinase inhibitor by relocation of a lysine residue by one helical turn.
    Winterburn TJ; Wyatt DM; Phylip LH; Berry C; Bur D; Kay J
    Biol Chem; 2006 Aug; 387(8):1139-42. PubMed ID: 16895485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics simulations of the three dimensional model of plasmepsin II-peptidic inhibitor complexes.
    Pranav Kumar SK; Kulkarni VM
    Drug Des Discov; 2001; 17(4):293-313. PubMed ID: 11765133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.
    Bailey D; Cooper JB
    Protein Sci; 1994 Nov; 3(11):2129-43. PubMed ID: 7703859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.